Clinical Research Management
Clinical Research Management (ClinicalRM) is a US-based, full-service Contract Research Organization founded in 1992 and acquired by ICON plc in February 2024, specializing in clinical trial management for government-sponsored research and vaccines/infectious disease trials.
- Company typePrivate
- Founded1992
- HeadquartersHinckley, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Clinical Research Management does
Clinical Research Management Inc. (ClinicalRM) is a US-based, full-service Contract Research Organization (CRO) founded in 1992 and headquartered in Hinckley, Ohio. The company provided clinical trial management services — including study design, execution, monitoring, and operational delivery — to government-sponsored research programs, with a particular concentration in vaccines and infectious disease clinical trials. This narrow specialization in federal research (likely spanning NIH-, BARDA-, and DoD-adjacent sponsors) defined its value proposition and differentiated it from commercial biopharma-oriented CROs.
Its business model revolved around program-based contracts with US government sponsors; pricing, contract structures, and per-study economics are not publicly disclosed. The company operated privately with a workforce of 251-500 employees, supported a business development function (evidenced by a VP of Business Development role), and served a horizontal customer segment centered on government-sponsored research and infectious disease trials. Core technology and proprietary platforms are not publicly disclosed, and the differentiation rests on operational expertise, regulatory familiarity with federal clinical research frameworks, and accumulated sponsor relationships rather than on disclosed product or technology assets.
In February 2024, ClinicalRM was acquired by ICON plc (NASDAQ: ICLR), a publicly traded Irish-headquartered global CRO. The acquisition was explicitly framed as a strategic move to expand ICON's capabilities in government-sponsored research and vaccines/infectious disease trials, integrating ClinicalRM's specialized expertise into ICON's broader clinical research services portfolio. Following the acquisition, ClinicalRM no longer operates as an independent entity, and its standalone forward trajectory is a function of ICON's portfolio strategy rather than independent capital allocation.
Clinical Research Management firmographics
Firmographics- Name
- Clinical Research Management
- Legal name
- Clinical Research Management Inc.
- Website
- https://clinicalrm.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Clinical Research Management (ClinicalRM) is a US-based, full-service Contract Research Organization founded in 1992 and acquired by ICON plc in February 2024, specializing in clinical trial management for government-sponsored research and vaccines/infectious disease trials.
- Ownership category
- akta.pro rank
Clinical Research Management industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Vaccine Clinical Development & Regulatory Affairs (HLAIAEAM)
- akta.pro secondary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Clinical Research Management is headquartered
LocationHeadquarters
- HQ city
- Hinckley
- HQ country
- United States
- HQ region
- North America
Markets served
Clinical Research Management business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Clinical Research Management product offering
Product offeringCore offering
Clinical Research Management (ClinicalRM) is a full-service Contract Research Organization that manages and conducts clinical trials for government-sponsored research programs, with specialized expertise in vaccines and infectious disease trials. The company provides end-to-end clinical trial support services from study design through execution for public-sector and biopharmaceutical sponsors.
Product overview
Based on the available source data, there is insufficient information to provide a detailed product overview for Clinical Research Management. The only reference indicates that ICON plc acquired Clinical Research Management Inc. in February 2024 to expand its capabilities in government-sponsored research and vaccines and infectious disease trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Management Services
- Government-Sponsored Research Support
Companies that use Clinical Research Management
Customer profileSegments2 records
Ideal customer profiles2 records
Clinical Research Management technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Clinical Research Management partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ICON plccoreIn February 2024, ICON plc acquired US-based Clinical Research Management Inc. to expand its capabilities in government-sponsored research and vaccines and infectious disease trials. This acquisition represents a strategic integration of CRM's specialized expertise into ICON plc's broader clinical research services portfolio.
Scale indicators1 record
Recent moves1 record
Expansion highlights3 records
Clinical Research Management competitors and assessment
Company assessmentDirect peers
Broad incumbents
- ICON plc: ICON plc is a global tier-1 CRO that acquired Clinical Research Management in February 2024. As the parent and acquirer, it is the most direct comparator for CRM's full-service clinical trial management capabilities and government/vaccine trial focus.
- IQVIA: IQVIA is the largest global CRO and life sciences technology provider. It competes with CRM for large government and biopharma clinical trial programs and operates across the same full-service CRO category, including vaccine and infectious disease work.
- Thermo Fisher Scientific (PPD): Thermo Fisher acquired PPD in 2021, making it one of the largest global CROs. PPD competes directly with CRM in clinical trial management for vaccines, infectious disease, and government-sponsored programs at global scale.
- Charles River Laboratories: Charles River is a major CRO and preclinical services provider with a strong vaccine and infectious disease research portfolio. It overlaps with CRM's vaccine and infectious disease trial focus and competes for government biodefense research contracts.
- Parexel International: Parexel is a tier-1 global CRO offering full-service clinical development across therapeutic areas including infectious disease and vaccines. Its scale and government/biopharma client base make it a direct competitor to CRM in mid-to-large clinical trial programs.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Clinical Research Management social profiles
Digital presenceClinical Research Management financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinical Research Management leadership team
Management profileNumber of profiles
Profiles1 record
Clinical Research Management funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinical Research Management M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinical Research Management
What does Clinical Research Management do?
Clinical Research Management (ClinicalRM) is a full-service Contract Research Organization that manages and conducts clinical trials for government-sponsored research programs, with specialized expertise in vaccines and infectious disease trials. The company provides end-to-end clinical trial support services from study design through execution for public-sector and biopharmaceutical sponsors.
Is Clinical Research Management a public or private company?
Clinical Research Management is a private company. It is classified as corporate owned and is currently acquired.
When was Clinical Research Management founded?
Clinical Research Management was founded in 1992. It employs 251 to 500 people.
Where is Clinical Research Management based?
Clinical Research Management is headquartered in Hinckley, United States, in the North America region.
Who are Clinical Research Management's main competitors?
Medpace Holdings is listed as a direct peer. Broad incumbents are ICON plc, IQVIA, Thermo Fisher Scientific (PPD), Charles River Laboratories and Parexel International.
Does Clinical Research Management have an API?
No public API is recorded for Clinical Research Management.
What industry is Clinical Research Management in?
Clinical Research Management's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAIAEAM, Vaccine Clinical Development & Regulatory Affairs, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 5417 and its SIC code is 8731.